4th Quarter - Report — BUCHANAN INGERSOLL & ROONEY PC for BIOFLORIDA, INC. (2025)

Firm

BUCHANAN INGERSOLL & ROONEY PC

Client

BIOFLORIDA, INC.

Income

$20,000

Expenses

—

What was lobbied

7 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

Lobbyist	Covered position, as disclosed
SOPHIA ESTUPINAN	—
AMANDA LINCOLN	Staff Director, Senate Health, Education, Labor, and Pensions Committee; Legislative Director, Sen. Mike Enzi; Health Policy Director, Sen. Susan Collins
MICHAEL P STRAZZELLA	—

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Copyright/Patent/Trademark CPT

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

Lobbyist	Covered position, as disclosed
SOPHIA ESTUPINAN	—
AMANDA LINCOLN	Staff Director, Senate Health, Education, Labor, and Pensions Committee; Legislative Director, Sen. Mike Enzi; Health Policy Director, Sen. Susan Collins
MICHAEL P STRAZZELLA	—

Contacted: Food & Drug Administration (FDA); SENATE; Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

Lobbyist	Covered position, as disclosed
SOPHIA ESTUPINAN	—
AMANDA LINCOLN	Staff Director, Senate Health, Education, Labor, and Pensions Committee; Legislative Director, Sen. Mike Enzi; Health Policy Director, Sen. Susan Collins
MICHAEL P STRAZZELLA	—

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Manufacturing MAN

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

Lobbyist	Covered position, as disclosed
SOPHIA ESTUPINAN	—
AMANDA LINCOLN	Staff Director, Senate Health, Education, Labor, and Pensions Committee; Legislative Director, Sen. Mike Enzi; Health Policy Director, Sen. Susan Collins
MICHAEL P STRAZZELLA	—

Contacted: SENATE; Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Medical/Disease Research/Clinical Labs MED

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

Lobbyist	Covered position, as disclosed
SOPHIA ESTUPINAN	—
AMANDA LINCOLN New	Staff Director, Senate Health, Education, Labor, and Pensions Committee; Legislative Director, Sen. Mike Enzi; Health Policy Director, Sen. Susan Collins
MICHAEL P STRAZZELLA	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA)

Medicare/Medicaid MMM

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

Lobbyist	Covered position, as disclosed
SOPHIA ESTUPINAN	—
AMANDA LINCOLN	Staff Director, Senate Health, Education, Labor, and Pensions Committee; Legislative Director, Sen. Mike Enzi; Health Policy Director, Sen. Susan Collins
MICHAEL P STRAZZELLA	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

Issues relating to Florida life sciences industry including biopharma, medtech, digital health and health systems.

Lobbyist	Covered position, as disclosed
SOPHIA ESTUPINAN	—
AMANDA LINCOLN	Staff Director, Senate Health, Education, Labor, and Pensions Committee; Legislative Director, Sen. Mike Enzi; Health Policy Director, Sen. Susan Collins
MICHAEL P STRAZZELLA	—

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.